C-Reactive Protein-Triglyceride-Glucose Index (CTI) is an Independent Predictor of Cardiovascular Mortality in Patients with Metabolic Syndrome | Synapse
March 3, 2026
C-Reactive Protein-Triglyceride-Glucose Index (CTI) is an Independent Predictor of Cardiovascular Mortality in Patients with Metabolic Syndrome
Key Points
Cardiovascular mortality is significantly predicted by the triglyceride-glucose index, a key measure of metabolic health.
A computed risk score indicates that patients with higher CTI values face a greater risk of mortality than those with lower scores.
Observational analysis across a cohort reveals that metabolic syndrome complications correlate with elevated CTI levels.
Further validation is necessary to assess CTI's role as a routine prognostic marker in wider patient populations.